Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02037594 · ClinicalTrials.gov registry record · NA

Intervention to Enhance PrEP Uptake and Adherence in a Community-Based Setting

A NA study, sponsored by Hunter College of City University of New York.

Completed
Registry status
NA
Development phase
438
Enrollment target

NCT02037594: Completed NA study, sponsored by Hunter College of City University of New York.

NCT02037594 is a NA study that has completed, run by Hunter College of City University of New York. The registered enrollment target is 438 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02037594, a NA study, has completed, sponsored by Hunter College of City University of New York.

COMPLETED
Registry status
NA
Development phase
438 participants
Enrollment target

Study Summary

This study identifies social and behavioral factors likely to influence PrEP acceptability and adherence among men who have sex with men (MSM), and collaborates with a community health center to evaluate a two-stage intervention to improve PrEP decision-making, as well as persistence and adherence for those who chose to take PrEP.

Primary Outcome

Whether or not the patient decides to take PrEP

Interventions

  • BEHAVIORAL Sexual Health Counseling
  • BEHAVIORAL Enhanced Adherence Intervention
  • BEHAVIORAL PrEP Information (Active Control)
  • BEHAVIORAL Standard of Care Adherence Support (Active Control)

Trial Details

FieldValue
Enrollment Target 438 participants
Start Date 2014-01-30
Est. Completion 2018-06-01
Phase NA

What the finished NCT02037594 record still lists

NCT02037594 is an interventional study that assigns participants to a tested intervention. The registered 438 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).

The record links to 0 conditions, and to 4 interventions - of which Sexual Health Counseling is the first listed.

NCT02037594 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02037594 about?

NCT02037594 is a clinical study titled "Intervention to Enhance PrEP Uptake and Adherence in a Community-Based Setting". This study identifies social and behavioral factors likely to influence PrEP acceptability and adherence among men who have sex with men (MSM), and collaborates with a community health center to evaluate a two-stage intervention to improve PrEP decision-making, as well as persistence and adherence f...

What is the current status of trial NCT02037594?

This trial is currently completed. It is a NA study. The enrollment target is 438 participants. The study started on 2014-01-30. Estimated completion is 2018-06-01.

What interventions are being tested in trial NCT02037594?

The interventions under investigation include: Sexual Health Counseling (BEHAVIORAL), Enhanced Adherence Intervention (BEHAVIORAL), PrEP Information (Active Control) (BEHAVIORAL), Standard of Care Adherence Support (Active Control) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02037594?

This trial is sponsored by Hunter College of City University of New York, which has 29 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02037594's enrollment target sits among peer trials

438 235th of 2000 higher than 1,766 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05711446 · 438 participants · NA

    Double Voiding and Post-transplant UTI

  • NCT05421663 · 439 participants · Phase 1

    A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma

  • NCT06235151 · 439 participants · Phase 3

    Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer

  • NCT05114538 · 440 participants · NA

    Improving the Part C Early Intervention Service Delivery System for Children with ASD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02037594, the US trial registry maintained by the National Library of Medicine. NCT02037594 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.